2018
DOI: 10.1002/hup.2679
|View full text |Cite
|
Sign up to set email alerts
|

Prohedonic properties of gamma‐hydroxybutyrate are associated with changes in limbic resting‐state functional connectivity

Abstract: Objective Gamma‐hydroxybutyrate (GHB) is an endogenous GHB‐/GABA‐B receptor agonist and a narcolepsy treatment. However, GHB is also abused for its prohedonic effects. On a neuronal level, it was shown that GHB increases regional cerebral blood flow in limbic areas such as the right anterior insula (rAI) and the anterior cingulate cortex (ACC). We aimed to further explore the association between the subjective and neuronal signatures of GHB. Method We assessed subjective effects and resting‐state functional co… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
8
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(8 citation statements)
references
References 69 publications
(133 reference statements)
0
8
0
Order By: Relevance
“…Few studies have noted treatment‐related changes in GABA and functional connectivity. It was found in one study that administration of Gamma‐hydroxybutyrate (a GABA agonist) increased right anterior insula functional connectivity (48). Due to the complex relationship between GABA and BOLD functional connectivity demonstrated across previous studies, our results need further validation.…”
Section: Discussionmentioning
confidence: 99%
“…Few studies have noted treatment‐related changes in GABA and functional connectivity. It was found in one study that administration of Gamma‐hydroxybutyrate (a GABA agonist) increased right anterior insula functional connectivity (48). Due to the complex relationship between GABA and BOLD functional connectivity demonstrated across previous studies, our results need further validation.…”
Section: Discussionmentioning
confidence: 99%
“…We also found, in one participant who showed decreased [C-11] raclopride binding in LST (i.e., increased dopamine), transient euphoria, a known (Bosch et al, 2018) but, in clinical trials, an uncommon event (Xyrem Product Monograph, 2018), potentially implicating limbic brain activation reported after SO (see Bosch et al, 2018). This raises the possibility that some might respond to SO with initial increase in dopamine release and consequent stimulant-like behavioral activation.…”
Section: Discussionmentioning
confidence: 54%
“…Sodium oxybate (SO; the sodium salt of γ-hydroxybutyrate) is a sedative drug used for treatment of cataplexy and excessive daytime sleepiness in narcolepsy (Carter et al, 2006;Xyrem Product Monograph, 2018). It may also be abused by recreational users (see Bosch et al, 2018). The brain mechanisms explaining effects of this endogenous GABA metabolite are not known, but preclinical data show that a major action of the drug is likely to be activation of the brain GABA B receptor (Kaupmann et al, 2003).…”
Section: Introductionmentioning
confidence: 99%
“…euphoria, disinhibition, enhanced vitality, amnesia, and has prosexual effects, for which the drug is used for illicit purposes (rape and theft). 7 Deep slow-wave sleep is induced at higher dosages, followed by coma and respiratory depression at very high dosages. The effects of GHB and alcohol are synergistic.…”
Section: Discussionmentioning
confidence: 99%